Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Ophthalmology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Glaucoma Clinical Trials

A listing of Glaucoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (187) clinical trials

This study looks at Bimatoprost Sustained Release (SR) implant compared to Selective Laser Trabeculoplasty in lowering the intraocular pressure of patients with Open-angle Glaucoma or Ocular Hypertension.

Phase N/A

This study will evaluate the efficacy and safety of bimatoprost sustained-release (SR) in patients with open-angle glaucoma or ocular hypertension. The study includes a 12-month treatment period with an 8-month extended follow-up.

Phase

A research study of an investigational eye plug containing a sustained release medication designed to lower the pressure inside your eye. This research study may be an option for you. Please see the eligibility criteria to see if you may qualify. Please reach out to our research staff if you ...

Phase

This study will evaluate the efficacy and safety of bimatoprost sustained-release (SR) in patients with open-angle glaucoma or ocular hypertension. The study includes a 12-month treatment period with an 8-month extended follow-up.

Phase N/A

Research study to lower eye pressure for patients with open-angle glaucoma or ocular hypertension.  

Phase

Eye Drop Dispensers: Safety Efficacy and Comfort.

subject will evaluate 2 dispensers by questioners. efficacy and safety of each one will be evaluated.

Phase N/A

Single-dose Study of ANX007 in Participants With Primary Open-angle Glaucoma

This is a phase 1, open-label, dose-escalation, safety study evaluating up to 3 dose levels of ANX007 administered as single IVT injections. Approximately 9 to 15 eligible participants are enrolled into one cohort each. All participants receive ANX007 in an open-label manner. The primary objective is to evaluate the safety ...

Phase

Efficacy and Necessity of Anti-inflammatory Drops After Laser Peripheral Iridotomy

Primary closed angle glaucoma is responsible to almost half glaucoma related blindness around the world. Laser peripheral iridotomy (LPI) is a common and simple treatment used for both treatment and prevention of acute angle closure event. Anti-inflammatory drops are commonly prescribed to patients undergoing LPI in order to prevent or ...

Phase N/A

Study of NT-501 Encapsulated Cell Therapy for Glaucoma Neuroprotection and Vision Restoration

This is a randomized, sham controlled, masked clinical trial of 60 study participants with glaucoma. Participants with a qualifying study eye will be randomized after screening and baseline evaluations to receive the NT-501 encapsulated cell therapy (ECT) implant or a sham surgery (control arm), and no explant will be required. ...

Phase

Functional and Structural Imaging for Glaucoma

Glaucoma is the second leading cause of blindness in the US. The diagnosis and monitoring of glaucoma are important problems, not only because of its prevalence, but also because of its silent and irreversible nature. However all of the current diagnostic tests have serious limitations. Although elevated intraocular pressure (IOP) ...

Phase N/A